Codexis Company Profile (NASDAQ:CDXS)

About Codexis (NASDAQ:CDXS)

Codexis logoCodexis, Inc. is a developer of biocatalysts for the pharmaceutical and fine chemicals markets. The Company's CodeEvolver protein engineering technology platform, which introduces genetic mutations into genes in order to give rise to changes in the enzymes that they produce, overcomes many of the limitations, allowing customers to evolve and optimize biocatalysts to perform specific and desired chemical reactions at commercial scale. The Company's pharmaceutical products include enzymes, pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and Codex Biocatalyst Panels and Kits. The fine chemicals market consists of several market verticals, including food and food ingredients, animal feed, flavors and fragrances, and agricultural chemicals. The Company also uses its technology to develop an early stage, enzyme therapeutic product candidate for the treatment of phenylketonuria (PKU) in humans through oral administration.

Industry, Sector and Symbol:
  • Sector: Industrial Products
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Symbol: NASDAQ:CDXS
  • CUSIP: 19200510
  • Web:
  • Market Cap: $207.13 million
  • Outstanding Shares: 48,169,000
Average Prices:
  • 50 Day Moving Avg: $4.48
  • 200 Day Moving Avg: $4.61
  • 52 Week Range: $3.60 - $5.28
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -39.09
  • P/E Growth: -1.05
Sales & Book Value:
  • Annual Revenue: $48.81 million
  • Price / Sales: 4.24
  • Book Value: $0.28 per share
  • Price / Book: 15.36
  • EBIDTA: ($5,500,000.00)
  • Net Margins: -10.60%
  • Return on Equity: -5.25%
  • Return on Assets: -2.69%
  • Debt-to-Equity Ratio: 0.04%
  • Current Ratio: 2.57%
  • Quick Ratio: 2.48%
  • Average Volume: 149,881 shs.
  • Beta: -1
  • Short Ratio: 12.3

Frequently Asked Questions for Codexis (NASDAQ:CDXS)

What is Codexis' stock symbol?

Codexis trades on the NASDAQ under the ticker symbol "CDXS."

How were Codexis' earnings last quarter?

Codexis, Inc. (NASDAQ:CDXS) released its quarterly earnings data on Tuesday, May, 9th. The company reported ($0.18) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.15) by $0.03. The business had revenue of $7.97 million for the quarter, compared to analyst estimates of $9.23 million. Codexis had a negative return on equity of 5.25% and a negative net margin of 10.60%. The company's revenue was down .4% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.11) earnings per share. View Codexis' Earnings History.

Where is Codexis' stock going? Where will Codexis' stock price be in 2017?

3 brokerages have issued 12-month price objectives for Codexis' shares. Their predictions range from $5.50 to $8.00. On average, they anticipate Codexis' stock price to reach $6.58 in the next twelve months. View Analyst Ratings for Codexis.

Are investors shorting Codexis?

Codexis saw a drop in short interest in April. As of April 13th, there was short interest totalling 1,185,218 shares, a drop of 13.1% from the March 31st total of 1,364,531 shares. Based on an average daily trading volume, of 401,154 shares, the short-interest ratio is presently 3.0 days.

Who are some of Codexis' key competitors?

Who are Codexis' key executives?

Codexis' management team includes the folowing people:

  • Bernard J. Kelley, Chairman of the Board
  • John J. Nicols, President, Chief Executive Officer, Director
  • Gordon T. Sangster, Chief Financial Officer, Senior Vice President
  • Douglas T. Sheehy J.D., Executive Vice President, Chief Administrative Officer, General Counsel, Secretary
  • Michael Douglas Arthur Aldridge, Senior Vice President - Corporate & Strategic Development
  • James Lalonde, Senior Vice President, Research & Development
  • Thomas R. Baruch J.D., Chairman Emeritus
  • Pam P. Cheng, Director
  • Kathleen Sereda Glaub, Director
  • Patrick Y. Yang, Director

Who owns Codexis stock?

Codexis' stock is owned by a number of of retail and institutional investors. Top institutional investors include FMR LLC (3.08%), Baillie Gifford & Co. (2.86%), Vanguard Group Inc. (2.60%), William Blair Investment Management LLC (2.38%), Renaissance Technologies LLC (1.92%) and Prescott Group Capital Management L.L.C. (0.70%). Company insiders that own Codexis stock include Bernard J Kelley, Dennis P Wolf, James Lalonde, Patrick Y Yang, Ventures Fund Vii LP Vivo and Vivo Ventures Vii, Llc. View Institutional Ownership Trends for Codexis.

Who sold Codexis stock? Who is selling Codexis stock?

Codexis' stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Renaissance Technologies LLC, Morgan Stanley, Alambic Investment Management L.P., Spark Investment Management LLC and Strs Ohio. Company insiders that have sold Codexis stock in the last year include Bernard J Kelley, Dennis P Wolf, Ventures Fund Vii LP Vivo and Vivo Ventures Vii, Llc. View Insider Buying and Selling for Codexis.

Who bought Codexis stock? Who is buying Codexis stock?

Codexis' stock was bought by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, Blair William & Co. IL, Essex Investment Management Co. LLC, Vanguard Group Inc., Tower Research Capital LLC TRC, Bank of New York Mellon Corp, Wells Fargo & Company MN and Geode Capital Management LLC. View Insider Buying and Selling for Codexis.

How do I buy Codexis stock?

Shares of Codexis can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Codexis' stock price today?

One share of Codexis stock can currently be purchased for approximately $4.30.

MarketBeat Community Rating for Codexis (NASDAQ CDXS)
Community Ranking:  2.3 out of 5 ( )
Outperform Votes:  58 (Vote Outperform)
Underperform Votes:  70 (Vote Underperform)
Total Votes:  128
MarketBeat's community ratings are surveys of what our community members think about Codexis and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Codexis (NASDAQ:CDXS) (?)
Ratings Breakdown: 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $6.58 (53.10% upside)

Analysts' Ratings History for Codexis (NASDAQ:CDXS)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/11/2017HC WainwrightSet Price TargetBuy$8.00HighView Rating Details
1/26/2017First AnalysisDowngradeOverweight -> Equal Weight$5.50N/AView Rating Details
1/4/2017Ladenburg Thalmann Financial ServicesUpgradeNeutral -> Buy$6.25N/AView Rating Details
(Data available from 5/29/2015 forward)


Earnings History for Codexis (NASDAQ:CDXS)
Earnings by Quarter for Codexis (NASDAQ:CDXS)
Earnings History by Quarter for Codexis (NASDAQ CDXS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2017Q1 2017($0.15)($0.18)$9.23 million$7.97 millionViewListenView Earnings Details
3/9/2017Q4 2016($0.11)($0.12)$9.15 million$10.00 millionViewListenView Earnings Details
11/8/2016Q3($0.14)$0.06$7.41 million$14.90 millionViewListenView Earnings Details
8/9/2016Q216$0.03$0.12$15.10 million$16.00 millionViewListenView Earnings Details
5/9/2016Q1($0.15)($0.11)$7.49 million$8.00 millionViewListenView Earnings Details
3/3/2016Q4($0.04)$0.02$11.63 million$11.60 millionViewN/AView Earnings Details
11/4/2015Q315($0.11)$0.13$8.85 million$17.40 millionViewListenView Earnings Details
8/11/2015Q215($0.14)($0.14)$7.34 million$6.02 millionViewListenView Earnings Details
5/7/2015Q115($0.12)($0.14)$8.00 million$6.80 millionViewListenView Earnings Details
3/3/2015Q414$0.01$0.07$13.30 million$14.20 millionViewListenView Earnings Details
11/4/2014Q314($0.06)($0.05)$9.00 million$7.47 millionViewListenView Earnings Details
8/6/2014Q214($0.15)($0.22)$8.50 million$6.60 millionViewListenView Earnings Details
5/7/2014Q114($0.10)($0.17)$10.00 million$7.10 millionViewListenView Earnings Details
3/11/2014Q413($0.21)($0.26)$10.00 million$9.50 millionViewListenView Earnings Details
11/12/2013Q313($0.31)($0.24)$8.50 million$3.90 millionViewListenView Earnings Details
8/9/2013Q2 2013($0.28)($0.33)$9.00 million$6.97 millionViewListenView Earnings Details
5/7/2013Q1 2013($0.36)($0.25)$7.63 million$11.48 millionViewListenView Earnings Details
2/27/2013Q4 2012($0.34)($0.41)$9.33 million$7.90 millionViewListenView Earnings Details
11/7/2012Q312($0.15)($0.06)$25.88 million$26.34 millionViewN/AView Earnings Details
8/9/2012($0.18)($0.15)ViewN/AView Earnings Details
5/10/2012($0.15)($0.21)ViewN/AView Earnings Details
2/7/2012($0.11)($0.15)ViewN/AView Earnings Details
11/1/2011($0.08)($0.08)ViewN/AView Earnings Details
7/28/2011($0.10)($0.14)ViewN/AView Earnings Details
5/5/2011($0.07)($0.10)ViewN/AView Earnings Details
2/3/2011($0.06)($0.01)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Codexis (NASDAQ:CDXS)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.10)($0.10)($0.10)
Q2 20171($0.12)($0.12)($0.12)
Q3 20171($0.14)($0.14)($0.14)
(Data provided by Zacks Investment Research)


Dividend History for Codexis (NASDAQ:CDXS)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Codexis (NASDAQ:CDXS)
Insider Ownership Percentage: 11.30%
Institutional Ownership Percentage: 57.65%
Insider Trades by Quarter for Codexis (NASDAQ:CDXS)
Institutional Ownership by Quarter for Codexis (NASDAQ:CDXS)
Insider Trades by Quarter for Codexis (NASDAQ:CDXS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/15/2016Patrick Y YangDirectorBuy10,000$4.83$48,300.00View SEC Filing  
9/8/2016Ventures Fund Vii L.P. VivoMajor ShareholderSell111,600$4.25$474,300.00View SEC Filing  
8/29/2016Dennis P WolfDirectorSell18,000$4.22$75,960.00View SEC Filing  
8/24/2016Bernard J KelleyDirectorSell12,643$4.26$53,859.18View SEC Filing  
8/16/2016Ventures Fund Vii L.P. VivoMajor ShareholderSell86,894$4.25$369,299.50View SEC Filing  
8/15/2016Vivo Ventures Vii, LlcMajor ShareholderSell50,000$4.27$213,500.00View SEC Filing  
8/4/2016Ventures Fund Vii L.P. VivoMajor ShareholderSell80,000$4.22$337,600.00View SEC Filing  
11/11/2015James LalondeSVPSell9,441$3.52$33,232.32View SEC Filing  
9/11/2015Patrick Y YangDirectorBuy10,000$3.47$34,700.00View SEC Filing  
9/10/2015Bernard J. KelleyDirectorSell5,200$3.45$17,940.00View SEC Filing  
8/24/2015Patrick Y YangDirectorBuy10,000$3.84$38,400.00View SEC Filing  
8/14/2015Patrick Y YangDirectorBuy20,000$3.97$79,400.00View SEC Filing  
6/15/2015Dennis P WolfDirectorSell35,416$4.10$145,205.60View SEC Filing  
11/18/2014Patrick Y YangDirectorBuy20,000$2.35$47,000.00View SEC Filing  
11/17/2014Patrick Y YangDirectorBuy20,000$2.34$46,800.00View SEC Filing  
8/12/2014Patrick Y YangDirectorBuy60,000$2.22$133,200.00View SEC Filing  
3/8/2013John J NicolsCEOBuy27,000$2.42$65,340.00View SEC Filing  
3/7/2013John J NicolsCEOBuy54,000$2.22$119,880.00View SEC Filing  
3/4/2013David D O'tooleCFOBuy10,000$2.02$20,200.00View SEC Filing  
11/12/2012David D O'tooleCFOBuy5,000$2.20$11,000.00View SEC Filing  
9/14/2012David D O'tooleCFOBuy5,000$2.78$13,900.00View SEC Filing  
9/14/2012Douglas T SheehySVPSell3,800$2.76$10,488.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Codexis (NASDAQ:CDXS)
Latest Headlines for Codexis (NASDAQ:CDXS)
DateHeadline logoZacks Investment Research Lowers Codexis, Inc. (CDXS) to Sell - May 23 at 6:16 PM logoHC Wainwright Analysts Give Codexis, Inc. (CDXS) a $8.00 Price Target - May 13 at 6:58 PM logoEdited Transcript of CDXS earnings conference call or presentation 9-May-17 8:30pm GMT - May 10 at 8:28 AM logoCodexis, Inc. (CDXS) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS - May 9 at 9:22 PM logoCodexis reports 1Q loss - May 9 at 7:04 PM logoInvestor Network: Codexis, Inc. to Host Earnings Call - May 9 at 4:12 PM logoCodexis Reports Financial Results for the First Quarter of 2017 - May 9 at 4:12 PM logoCodexis, Inc. (CDXS) Short Interest Update - May 4 at 11:22 PM logoCodexis (CDXS) Receiving Very Positive News Coverage, Study Finds - May 4 at 7:32 AM logoDelta Technology Holdings Is A Deep Value Play On The Fine Chemical Industry Rebound In China - May 2 at 3:59 PM logoCodexis to Hold 2017 First Quarter Conference Call on May 9 - May 2 at 11:49 AM logoCodexis (CDXS) Getting Somewhat Negative News Coverage, Analysis Shows - May 1 at 3:50 PM logoZacks: Analysts Anticipate Codexis, Inc. (CDXS) Will Announce Quarterly Sales of $8.84 Million - April 29 at 8:48 AM logo-$0.15 Earnings Per Share Expected for Codexis, Inc. (CDXS) This Quarter - April 27 at 5:18 PM logoSomewhat Critical Press Coverage Very Likely to Impact Codexis (CDXS) Share Price - April 27 at 5:14 PM logo Brokerages Anticipate Codexis, Inc. (CDXS) Will Post Quarterly Sales of $8.84 Million - April 8 at 9:48 AM logoCodexis Announces Pricing of Public Offering of Common Stock - April 7 at 4:13 PM logoCodexis Announces Proposed Public Offering of Common Stock - April 7 at 8:54 AM logoZacks: Analysts Expect Codexis, Inc. (CDXS) to Post -$0.15 EPS - April 6 at 4:45 PM logoCodexis (CDXS) Secures 2nd Multi-Year Agreement in Food Industry with Tate & Lyle - March 31 at 9:23 PM logoCodexis Signs Second Multi-Year Agreement in Food Industry with Tate & Lyle - March 31 at 4:22 PM logoCodexis, Inc. :CDXS-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017 - March 15 at 4:35 PM logoEdited Transcript of CDXS earnings conference call or presentation 9-Mar-17 9:30pm GMT - March 10 at 5:12 PM logoQ4 2016 Codexis Inc Earnings Release - After Market Close - March 9 at 4:48 PM logoCodexis Reports 2016 Fourth Quarter and Full Year Financial Results - March 9 at 4:48 PM logoCODEXIS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits - March 9 at 4:48 PM logoCodexis Inc Earnings Call scheduled for 4:30 pm ET today - March 9 at 4:48 PM logoCodexis to Hold 2016 Fourth Quarter and Full Year Conference Call on March 9 - March 2 at 7:54 AM logoWhat's in Store for KBR Inc. (KBR) this Earnings Season? - February 21 at 2:25 PM logoQuanta Services (PWR) Q4 Earnings: What's in the Cards? - February 16 at 9:02 AM logoDeere (DE) Q1 Earnings: A Beat in Store for the Stock? - February 13 at 4:49 PM logoShould Codexis (CDXS) Be On Your Radar Now? - January 9 at 5:23 PM logoCodexis upgraded by Ladenburg Thalmann - January 4 at 5:15 PM logoThe Zacks Analyst Blog Highlights: Codexis, EMCORE, Intevac, Organovo Holdings and StarTek - January 4 at 5:15 PM logo5 of the Best Stocks Under $10 for 2017 - January 3 at 5:52 PM logoCodexis to Commercially Supply Proprietary Enzyme to Tate & Lyle - December 6 at 12:02 PM logo7:03 am Codexis appoints Bernard J. Kelley as Chairman, effective November 29 - December 2 at 4:34 PM logoCodexis (CDXS) Appoints New Board Chair - December 1 at 4:19 PM logoCODEXIS INC Financials - November 17 at 3:20 PM logoCodexis to Present at the 7th Annual Craig-Hallum Alpha Select Conference - November 10 at 12:01 PM logoEdited Transcript of CDXS earnings conference call or presentation 8-Nov-16 9:30pm GMT - November 9 at 4:08 PM logoQ3 2016 Codexis Inc Earnings Release - After Market Close - November 8 at 2:32 PM logoCODEXIS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation - October 20 at 3:38 PM logoCODEXIS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits - October 5 at 4:24 PM logoCodexis to Present at September Investment Conferences - September 6 at 8:56 AM logoHow Codexis (CDXS) Stock Stands Out in a Strong Industry - August 18 at 12:29 PM logoEdited Transcript of CDXS earnings conference call or presentation 9-Aug-16 8:30pm GMT - August 10 at 3:37 PM logoCodexis Reports Financial Results for the Second Quarter of 2016 - August 9 at 9:56 PM logoQ2 2016 Codexis Inc Earnings Release - After Market Close - August 9 at 12:47 PM logoIndustrial Stocks' Aug 9 Earnings Preview: LABL, CDXS & More - August 8 at 8:56 AM



Codexis (CDXS) Chart for Monday, May, 29, 2017

This page was last updated on 5/29/2017 by Staff